1Powell B, Soong R, Iacopetta B, et al. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res, 2000,6:443-451.
2Bazan V, Zanna I, Migliavacea M, et al. Prognostic significance of p16INK4a alterations and 9p21 loss of heterezygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol , 2002,192: 286-293.
3Kudoh K, Ichikawa Y, Yoahida S, et al. Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer, Int J Cancer,2002,99:579-582.
4Byeon IL, Li JJ, Ericson K, et al. Tumor suppressor p16INK4A : determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol Cell, 1998,1:421-431.
5Yang R, Gombart AF,Serrano M, et al . Mutation effect on the p16INK4a tumor suppressor protein. Cancer Res, 1995,55 : 2503-2506.
6Russo A, Tong L, Lee JO, et al. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumor suppressor p16INK4a. Nature,1998,395 : 237-243.
7Li YW, Bhuiyan M, Vaitkevicius VK, et al. Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma.Pancreas, 1999,18:104-110.
8Serrano M,Hannon GJ,Beach D.A new regulatory motif in cell-cycle control causing specitic inhibition of cyclin D/CDK4. Nature, 1993,366:704-707.
9Igaki H, Sasaki H, Kishi T, et al. Highly frequent homozygous deletion of the esophageal cancer cell lines. Biochem Biophys Res Commun, 1994,203:1090-1095.
10Mori T, Miura K, Aoki T, et al. Frequent somatic mutation MTSI/CDK41 gene in esophageal squamous cell carcinoma. Cancer Res, 1994.54: 3396-3397.
